The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

UnitedHealth's revenue faces risks from potential Medicare and Medicaid budget cuts. See here to know why I have revised my ...

Vertex Pharmaceuticals (NASDAQ:VRTX) ended a four-day winning streak on Thursday after UnitedHealth (NYSE:UNH) placed its new ...

A court-appointed special master has found that U.S. authorities do not have evidence to support their billion-dollar fraud ...

CVS (CVS) in membership gains, while Medicare Advantage growth slows to the lowest rate in a decade. Read more here.

UnitedHealth acquired or created 250 subsidiaries in 2024 as it pursues an ambitious vertical integration strategy.

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

The civil fraud case against UnitedHealth Group, the nation’s largest Medicare Advantage insurer, was filed in 2011.

A court-appointed special master says the Justice Department hasn’t developed “any evidence” for key claims. Her ...

UnitedHealth Group notched a major court win in a legal challenge over its Medicare Advantage (MA) billing practices that is ...

The U.S. Justice Department is investigating UnitedHealth's Medicare billing practices, the Wall Street Journal reported on ...

The Justice Department lacks evidence to support claims the company withheld Medicare Advantage funds, a legal expert ...